Actively Recruiting
Korean Heart Failure Registry III
Led by Seoul National University Bundang Hospital · Updated on 2020-04-01
10000
Participants Needed
1
Research Sites
482 weeks
Total Duration
On this page
Sponsors
S
Seoul National University Bundang Hospital
Lead Sponsor
K
Korean Society of Heart Failure
Collaborating Sponsor
AI-Summary
What this Trial Is About
KorHF III is a multi-center, nationwide, prospective registry of the Korean Society of Heart Failure, which enrolls patients with acute heart failure in Korea. The aim of this registry is to analyze the etiology, treatment, treatment, and prognosis to develop strategies for managing acute heart failure.
CONDITIONS
Official Title
Korean Heart Failure Registry III
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients hospitalized with heart failure
- Symptoms of heart failure
- Signs of heart failure
- Lung congestion shown on chest x-ray
- Evidence of structural or functional heart disorder or elevated natriuretic peptide levels
You will not qualify if you...
- Patients younger than 18 years old
- Patients who do not consent to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Bundang Hospital
Seongnam, South Korea, 463707
Actively Recruiting
Research Team
D
Dong-Ju Choi, MD, PhD
CONTACT
J
Jin Joo Park, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here